Highlights Mertiva AB

Equities

MERT A

SE0010023432

End-of-day quote NORDIC GROWTH MARKET Other stock markets
- ^SEK	-

2017	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
2017	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	17-08-27	CI
Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	17-08-10	CI
Sanofi Pasteur Inc. agreed to acquire Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others for $750 million	17-07-10	CI
Mertiva AB's Equity Buyback announced on December 6, 2012, has expired.	15-11-28	CI
Mertiva AB (OTCPK:DMYD.F) acquired an additional 0.54% stake in Protein Sciences Corporation for $0.62 million.	14-12-17	CI
Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	14-01-21	CI
Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	13-10-11	CI
The members of the management of Diamyd, Inc. cancelled the acquisition of 90% stake in Diamyd Inc. from Diamyd Medical AB (OM:DIAM B).	13-10-08	CI
Mertiva AB (OTCPK:DMYD.F) acquired an additional 7.27% stake in Protein Sciences Corporation from Pacific Rim Ventures Co., Ltd. and other shareholders for $8.4 million.	13-09-25	CI
Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	13-07-04	CI
Tranche Update on Diamyd Medical AB's Equity Buyback Plan announced on December 6, 2012.	13-03-27	CI
Östersjöstiftelsen, Endowment Arm sold 5.1% stake in Diamyd Medical AB (OM:DIAM B).	13-03-06	CI
Diamyd Medical AB Announces New Clinical Study with Diamyd's Diabetes Vaccine	13-01-30	CI
Diamyd Medical AB's Equity Buyback has expired	12-12-06	CI
Mertiva AB announces an Equity Buyback.	12-12-05	CI
Tranche Update on Diamyd Medical AB's Equity Buyback Plan announced on December 7, 2011.	12-12-05	CI
Diamyd Medical AB Seeks Approval for an Equity Buyback	12-11-05	CI
Tranche Update on Diamyd Medical AB's Equity Buyback Plan announced on December 7, 2011.	12-10-31	CI
Diamyd Medical AB Limits Further Investment in the Diabetes Vaccine	12-10-29	CI
The members of the management of Diamyd, Inc. entered into an agreement to acquire 90% stake in Diamyd Inc. from Diamyd Medical AB (OM:DIAM B) for $10 million.	12-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mertiva AB

Equities

MERT A

SE0010023432

Highlights

Filters